Hikma Pharmaceuticals Plc Net Income 2016-2018 | HKMPF

Hikma Pharmaceuticals Plc annual/quarterly net income history and growth rate from 2016 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Hikma Pharmaceuticals Plc net income for the quarter ending December 31, 2018 was $M, a NAN% increase year-over-year.
  • Hikma Pharmaceuticals Plc net income for the twelve months ending December 31, 2018 was $0M, a NAN% increase year-over-year.
  • Hikma Pharmaceuticals Plc annual net income for 2018 was $0B, a 100% decline from 2017.
  • Hikma Pharmaceuticals Plc annual net income for 2017 was $-0.843B, a 643.87% decline from 2016.
  • Hikma Pharmaceuticals Plc annual net income for 2016 was $0.155B, a 38.49% decline from 2015.
Hikma Pharmaceuticals Plc Annual Net Income
(Millions of US $)
2018 $
2017 $-843
2016 $155
2015 $252
Hikma Pharmaceuticals Plc Quarterly Net Income
(Millions of US $)
Q4 2018
Q2 2018
Q4 2017
Q2 2017
Q4 2016
Q4 2015
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $5.781B $2.070B
Hikma Pharmaceuticals PLC develops, manufactures and markets pharmaceutical products. Its brand portfolio includes branded, injectables and generic. Branded segment offers dosage forms and strengths in the anti-infective, cardiovascular, diabetes, central nervous system, oncology and respiratory. Injectables segment offers dosage for CNS, controlled substances, anti-infective, cardiovascular and oncology in form of liquid, semi-liquid and powdered form. Generics segment offers dosage for therapeutic including analgesic, anti-infective, anti-inflammatory, cardiovascular, CNS, respiratory and hormonal. Hikma Pharmaceuticals PLC is based in London, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $58.463B 36.01
Astellas Pharma (ALPMY) Japan $27.878B 13.28
Takeda Pharmaceutical (TAK) Japan $27.185B 8.49
UCB SA (UCBJF) Belgium $14.267B 0.00
Eisai (ESALY) Japan $14.254B 24.51
Merck (MKGAF) Germany $14.152B 19.31
Grifols, S.A (GRFS) Spain $13.648B 17.41
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $9.287B 0.00
Ionis Pharmaceuticals (IONS) United States $9.102B 19.63
IPSEN SA ADR (IPSEY) France $8.529B 0.00
Sage Therapeutics (SAGE) United States $8.489B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.461B 9.82
Catalent (CTLT) United States $7.424B 29.39
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.052B 18.16
United Therapeutics (UTHR) United States $3.765B 0.00
Nektar Therapeutics (NKTR) United States $3.628B 0.00
FibroGen (FGEN) United States $3.599B 90.02
Evotec AG (EVTCY) Germany $3.399B 46.53
Taro Pharmaceutical Industries (TARO) Israel $3.166B 11.35
Tilray (TLRY) Canada $2.978B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.801B 64.22
PTC Therapeutics (PTCT) United States $2.554B 0.00
Portola Pharmaceuticals (PTLA) United States $2.102B 0.00
Xencor (XNCR) United States $2.068B 45.10
Zogenix (ZGNX) United States $1.887B 0.00
Heron Therapeutics (HRTX) United States $1.707B 0.00
USANA Health Sciences (USNA) United States $1.588B 15.92
Pacira Pharmaceuticals (PCRX) United States $1.580B 57.50
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Corcept Therapeutics (CORT) United States $1.534B 21.08
Ironwood Pharmaceuticals (IRWD) United States $1.490B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.357B 22.39
Radius Health (RDUS) United States $1.343B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.283B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.065B 0.00
Aerie Pharmaceuticals (AERI) United States $1.047B 0.00
ArQule (ARQL) United States $0.952B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.948B 4.23
Endo (ENDP) Ireland $0.928B 1.63
TherapeuticsMD (TXMD) United States $0.921B 0.00
Karyopharm Therapeutics (KPTI) United States $0.723B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.676B 0.00
Concordia (CXRXF) Canada $0.674B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.586B 0.00
Akebia Therapeutics (AKBA) United States $0.566B 0.00
Translate Bio (TBIO) United States $0.561B 0.00
Lannett Co Inc (LCI) United States $0.556B 5.86
Organogenesis Holdings (ORGO) United States $0.552B 0.00
Flexion Therapeutics (FLXN) United States $0.552B 0.00
Aptorum Group (APM) China $0.492B 0.00
ImmunoGen (IMGN) United States $0.481B 0.00
Dermira (DERM) United States $0.472B 0.00
Indivior (INVVY) United States $0.468B 1.69
Siga Technologies (SIGA) United States $0.467B 1.09
Innate Pharma SA (IPHYF) France $0.455B 0.00
Dova Pharmaceuticals (DOVA) United States $0.450B 0.00
ChemoCentryx (CCXI) United States $0.440B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.428B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.426B 19.39
Collegium Pharmaceutical (COLL) United States $0.406B 0.00
Harpoon Therapeutics (HARP) United States $0.379B 0.00
DURECT (DRRX) United States $0.365B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.361B 0.00
OptiNose (OPTN) United States $0.347B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.321B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.307B 0.00
CV Sciences (CVSI) United States $0.302B 0.00
Ardelyx (ARDX) United States $0.294B 0.00
Xeris Pharmaceuticals (XERS) United States $0.290B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.278B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.277B 0.00
Rafael Holdings (RFL) United States $0.272B 0.00
Recro Pharma (REPH) United States $0.268B 0.00
Concert Pharmaceuticals (CNCE) United States $0.264B 0.00
KalVista Pharmaceuticals (KALV) United States $0.261B 0.00
Molecular Templates (MTEM) United States $0.236B 0.00
Calithera Biosciences (CALA) United States $0.215B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.215B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.207B 0.00
Ocular Therapeutix (OCUL) United States $0.203B 0.00
GlycoMimetics (GLYC) United States $0.203B 0.00
Nature's Sunshine Products (NATR) United States $0.189B 31.55
CannTrust Holdings (CTST) Canada $0.183B 0.00
Generex Biotechnology (GNBT) United States $0.174B 0.00
Redhill Biopharma (RDHL) Israel $0.169B 0.00
Taiwan Liposome (TLC) Taiwan $0.160B 0.00
IMV INC (IMV) Canada $0.155B 0.00
MEI Pharma (MEIP) United States $0.142B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.135B 0.00
Cardiome Pharma (CORV) Canada $0.126B 0.00
ElectroCore (ECOR) United States $0.120B 0.00
Jounce Therapeutics (JNCE) United States $0.112B 0.00
Majesco Entertainment (PTE) United States $0.109B 0.00
Mast Therapeutics (SVRA) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.106B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.105B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.104B 0.00
Neos Therapeutics (NEOS) United States $0.094B 0.00
AgeX Therapeutics (AGE) United States $0.093B 0.00
Genocea Biosciences (GNCA) United States $0.092B 0.00
MediWound (MDWD) Israel $0.092B 0.00
Aquestive Therapeutics (AQST) United States $0.091B 0.00
Iterum Therapeutics (ITRM) Ireland $0.091B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.089B 0.00
RENEURON GP (RNUGF) United Kingdom $0.084B 0.00
Nivalis Therapeutics (ALPN) United States $0.077B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.075B 28.59
Aclaris Therapeutics (ACRS) United States $0.074B 0.00
Jaguar Animal Health (JAGX) United States $0.074B 0.00
Natural Alternatives (NAII) United States $0.073B 7.30
Lipocine (LPCN) United States $0.070B 0.00
Novan (NOVN) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.069B 592.00
Infinity Pharmaceuticals (INFI) United States $0.068B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.067B 0.00
Otonomy (OTIC) United States $0.066B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.062B 0.00
SCYNEXIS (SCYX) United States $0.061B 0.00
China SXT Pharmaceuticals (SXTC) China $0.059B 0.00
Capnia (SLNO) United States $0.058B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.053B 0.00
CTI BioPharma (CTIC) United States $0.049B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.047B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.046B 0.00
Melinta Therapeutics (MLNT) United States $0.046B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.046B 1.59
Forward Pharma (FWP) Denmark $0.045B 0.00
India Globalization Capital (IGC) United States $0.042B 0.00
Mannatechorporated (MTEX) United States $0.039B 0.00
Bio-Path Holdings (BPTH) United States $0.034B 0.00
Opexa Therapeutics (ACER) United States $0.034B 0.00
PharmAthene (ALT) United States $0.033B 0.00
Biomerica (BMRA) United States $0.031B 0.00
IsoRay (ISR) United States $0.021B 0.00
Heat Biologics (HTBX) United States $0.020B 0.00
ProPhase Labs (PRPH) United States $0.019B 0.00
Achieve Life Sciences (ACHV) United States $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Vical (BBI) United States $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.013B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Onconova Therapeutics (ONTX) United States $0.011B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Hemispherx BioPharma (AIM) United States $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00